nodes	percent_of_prediction	percent_of_DWPC	metapath
Benzatropine—CYP2D6—Lomustine—brain cancer	0.339	0.569	CbGbCtD
Benzatropine—CYP2D6—Hydroxyurea—brain cancer	0.257	0.431	CbGbCtD
Benzatropine—HRH1—nose—brain cancer	0.0234	0.169	CbGeAlD
Benzatropine—SLC6A3—telencephalic ventricle—brain cancer	0.0183	0.132	CbGeAlD
Benzatropine—SLC6A3—ganglion—brain cancer	0.0114	0.0823	CbGeAlD
Benzatropine—Disorientation—Lomustine—brain cancer	0.0105	0.0568	CcSEcCtD
Benzatropine—SLC6A3—hindbrain—brain cancer	0.00866	0.0624	CbGeAlD
Benzatropine—Apathy—Temozolomide—brain cancer	0.00693	0.0376	CcSEcCtD
Benzatropine—Flat affect—Temozolomide—brain cancer	0.00686	0.0373	CcSEcCtD
Benzatropine—Disorientation—Procarbazine—brain cancer	0.00664	0.0361	CcSEcCtD
Benzatropine—Memory impairment—Temozolomide—brain cancer	0.0063	0.0342	CcSEcCtD
Benzatropine—SLC6A3—Dopaminergic Neurogenesis—OTX2—brain cancer	0.00607	0.085	CbGpPWpGaD
Benzatropine—Disorientation—Hydroxyurea—brain cancer	0.00514	0.0279	CcSEcCtD
Benzatropine—Dysphagia—Procarbazine—brain cancer	0.00513	0.0279	CcSEcCtD
Benzatropine—SLC6A3—brainstem—brain cancer	0.00496	0.0358	CbGeAlD
Benzatropine—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00455	0.0638	CbGpPWpGaD
Benzatropine—CHRM2—telencephalon—brain cancer	0.00442	0.0318	CbGeAlD
Benzatropine—SLC6A3—telencephalon—brain cancer	0.0044	0.0317	CbGeAlD
Benzatropine—Body temperature increased—Carboplatin—brain cancer	0.00415	0.0226	CcSEcCtD
Benzatropine—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00414	0.058	CbGpPWpGaD
Benzatropine—CHRM1—telencephalon—brain cancer	0.00402	0.029	CbGeAlD
Benzatropine—Decreased appetite—Lomustine—brain cancer	0.004	0.0217	CcSEcCtD
Benzatropine—CYP2D6—hindbrain—brain cancer	0.00382	0.0276	CbGeAlD
Benzatropine—Dysuria—Hydroxyurea—brain cancer	0.00371	0.0202	CcSEcCtD
Benzatropine—Body temperature increased—Lomustine—brain cancer	0.00363	0.0197	CcSEcCtD
Benzatropine—Cyclizine—CYP2C9—brain cancer	0.00353	0.347	CrCbGaD
Benzatropine—CYP2C19—CYP2E1 reactions—CYP2C9—brain cancer	0.00353	0.0494	CbGpPWpGaD
Benzatropine—Tension—Procarbazine—brain cancer	0.00351	0.0191	CcSEcCtD
Benzatropine—Nervousness—Procarbazine—brain cancer	0.00347	0.0189	CcSEcCtD
Benzatropine—CYP2D6—CYP2E1 reactions—CYP2C9—brain cancer	0.00325	0.0455	CbGpPWpGaD
Benzatropine—Dysphagia—Carmustine—brain cancer	0.00321	0.0174	CcSEcCtD
Benzatropine—SLC6A3—midbrain—brain cancer	0.00316	0.0228	CbGeAlD
Benzatropine—Dysphagia—Temozolomide—brain cancer	0.0031	0.0169	CcSEcCtD
Benzatropine—SLC6A3—spinal cord—brain cancer	0.00308	0.0222	CbGeAlD
Benzatropine—Dry mouth—Procarbazine—brain cancer	0.00298	0.0162	CcSEcCtD
Benzatropine—Confusional state—Procarbazine—brain cancer	0.00294	0.016	CcSEcCtD
Benzatropine—Vomiting—Lomustine—brain cancer	0.00292	0.0159	CcSEcCtD
Benzatropine—Dysuria—Temozolomide—brain cancer	0.0029	0.0158	CcSEcCtD
Benzatropine—Tachycardia—Procarbazine—brain cancer	0.00285	0.0155	CcSEcCtD
Benzatropine—CHRM2—endocrine gland—brain cancer	0.00278	0.0201	CbGeAlD
Benzatropine—CHRM2—head—brain cancer	0.00275	0.0198	CbGeAlD
Benzatropine—SLC6A3—head—brain cancer	0.00274	0.0198	CbGeAlD
Benzatropine—Nausea—Lomustine—brain cancer	0.00273	0.0148	CcSEcCtD
Benzatropine—SLC6A3—Dopaminergic Neurogenesis—GLI2—brain cancer	0.00264	0.037	CbGpPWpGaD
Benzatropine—Hypoaesthesia—Carmustine—brain cancer	0.00256	0.0139	CcSEcCtD
Benzatropine—HRH1—telencephalon—brain cancer	0.00256	0.0184	CbGeAlD
Benzatropine—Decreased appetite—Procarbazine—brain cancer	0.00254	0.0138	CcSEcCtD
Benzatropine—CHRM1—endocrine gland—brain cancer	0.00253	0.0183	CbGeAlD
Benzatropine—CHRM2—central nervous system—brain cancer	0.00251	0.0181	CbGeAlD
Benzatropine—CHRM1—head—brain cancer	0.0025	0.018	CbGeAlD
Benzatropine—SLC6A3—central nervous system—brain cancer	0.0025	0.018	CbGeAlD
Benzatropine—Constipation—Procarbazine—brain cancer	0.0025	0.0136	CcSEcCtD
Benzatropine—Modafinil—CYP2C9—brain cancer	0.00249	0.245	CrCbGaD
Benzatropine—Dysphagia—Etoposide—brain cancer	0.00248	0.0135	CcSEcCtD
Benzatropine—SLC6A3—Dopaminergic Neurogenesis—GLI1—brain cancer	0.00248	0.0348	CbGpPWpGaD
Benzatropine—Hypoaesthesia—Temozolomide—brain cancer	0.00247	0.0134	CcSEcCtD
Benzatropine—SLC6A3—cerebellum—brain cancer	0.00245	0.0176	CbGeAlD
Benzatropine—Cinnarizine—CYP2C9—brain cancer	0.00241	0.237	CrCbGaD
Benzatropine—Feeling abnormal—Procarbazine—brain cancer	0.00241	0.0131	CcSEcCtD
Benzatropine—Body temperature increased—Procarbazine—brain cancer	0.00231	0.0125	CcSEcCtD
Benzatropine—CHRM1—central nervous system—brain cancer	0.00228	0.0165	CbGeAlD
Benzatropine—CYP2D6—brainstem—brain cancer	0.00219	0.0158	CbGeAlD
Benzatropine—CYP2C19—Xenobiotics—CYP2C9—brain cancer	0.00219	0.0306	CbGpPWpGaD
Benzatropine—Hypersensitivity—Procarbazine—brain cancer	0.00215	0.0117	CcSEcCtD
Benzatropine—Vision blurred—Carmustine—brain cancer	0.00211	0.0115	CcSEcCtD
Benzatropine—CYP2C19—endocrine gland—brain cancer	0.00211	0.0152	CbGeAlD
Benzatropine—CYP2C19—Tamoxifen metabolism—CYP2C9—brain cancer	0.0021	0.0295	CbGpPWpGaD
Benzatropine—Vision blurred—Temozolomide—brain cancer	0.00204	0.0111	CcSEcCtD
Benzatropine—CYP2D6—Xenobiotics—CYP2C9—brain cancer	0.00201	0.0282	CbGpPWpGaD
Benzatropine—CHRM2—brain—brain cancer	0.00199	0.0144	CbGeAlD
Benzatropine—SLC6A3—brain—brain cancer	0.00199	0.0143	CbGeAlD
Benzatropine—Hypoaesthesia—Etoposide—brain cancer	0.00198	0.0107	CcSEcCtD
Benzatropine—Decreased appetite—Hydroxyurea—brain cancer	0.00196	0.0107	CcSEcCtD
Benzatropine—CYP2D6—telencephalon—brain cancer	0.00194	0.014	CbGeAlD
Benzatropine—CYP2D6—Tamoxifen metabolism—CYP2C9—brain cancer	0.00193	0.0271	CbGpPWpGaD
Benzatropine—Constipation—Hydroxyurea—brain cancer	0.00193	0.0105	CcSEcCtD
Benzatropine—Feeling abnormal—Hydroxyurea—brain cancer	0.00186	0.0101	CcSEcCtD
Benzatropine—Vomiting—Procarbazine—brain cancer	0.00186	0.0101	CcSEcCtD
Benzatropine—Confusional state—Carmustine—brain cancer	0.00184	0.01	CcSEcCtD
Benzatropine—Rash—Procarbazine—brain cancer	0.00184	0.01	CcSEcCtD
Benzatropine—Dermatitis—Procarbazine—brain cancer	0.00184	0.00999	CcSEcCtD
Benzatropine—CHRM1—brain—brain cancer	0.00181	0.0131	CbGeAlD
Benzatropine—Dry mouth—Temozolomide—brain cancer	0.0018	0.00978	CcSEcCtD
Benzatropine—SLC6A3—Dopaminergic Neurogenesis—SHH—brain cancer	0.00179	0.0251	CbGpPWpGaD
Benzatropine—Body temperature increased—Hydroxyurea—brain cancer	0.00179	0.0097	CcSEcCtD
Benzatropine—Tachycardia—Carmustine—brain cancer	0.00178	0.00968	CcSEcCtD
Benzatropine—Confusional state—Temozolomide—brain cancer	0.00178	0.00967	CcSEcCtD
Benzatropine—Nausea—Procarbazine—brain cancer	0.00173	0.00942	CcSEcCtD
Benzatropine—Diphenhydramine—CYP2C9—brain cancer	0.00173	0.17	CrCbGaD
Benzatropine—Hypersensitivity—Hydroxyurea—brain cancer	0.00166	0.00904	CcSEcCtD
Benzatropine—HRH1—endocrine gland—brain cancer	0.00161	0.0116	CbGeAlD
Benzatropine—HRH1—head—brain cancer	0.00159	0.0115	CbGeAlD
Benzatropine—Decreased appetite—Carmustine—brain cancer	0.00159	0.00862	CcSEcCtD
Benzatropine—Constipation—Carmustine—brain cancer	0.00156	0.00848	CcSEcCtD
Benzatropine—Decreased appetite—Temozolomide—brain cancer	0.00153	0.00833	CcSEcCtD
Benzatropine—Constipation—Temozolomide—brain cancer	0.00151	0.0082	CcSEcCtD
Benzatropine—Feeling abnormal—Carmustine—brain cancer	0.00151	0.00818	CcSEcCtD
Benzatropine—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.0015	0.021	CbGpPWpGaD
Benzatropine—Feeling abnormal—Temozolomide—brain cancer	0.00145	0.0079	CcSEcCtD
Benzatropine—HRH1—central nervous system—brain cancer	0.00145	0.0105	CbGeAlD
Benzatropine—Body temperature increased—Carmustine—brain cancer	0.00144	0.00784	CcSEcCtD
Benzatropine—Vomiting—Hydroxyurea—brain cancer	0.00144	0.0078	CcSEcCtD
Benzatropine—Rash—Hydroxyurea—brain cancer	0.00142	0.00774	CcSEcCtD
Benzatropine—Confusional state—Etoposide—brain cancer	0.00142	0.00774	CcSEcCtD
Benzatropine—Dermatitis—Hydroxyurea—brain cancer	0.00142	0.00773	CcSEcCtD
Benzatropine—Body temperature increased—Temozolomide—brain cancer	0.0014	0.00758	CcSEcCtD
Benzatropine—Tachycardia—Etoposide—brain cancer	0.00138	0.00749	CcSEcCtD
Benzatropine—Hypersensitivity—Carmustine—brain cancer	0.00135	0.00731	CcSEcCtD
Benzatropine—Nausea—Hydroxyurea—brain cancer	0.00134	0.00729	CcSEcCtD
Benzatropine—Hypersensitivity—Temozolomide—brain cancer	0.0013	0.00706	CcSEcCtD
Benzatropine—Decreased appetite—Etoposide—brain cancer	0.00123	0.00667	CcSEcCtD
Benzatropine—CYP2D6—endocrine gland—brain cancer	0.00123	0.00885	CbGeAlD
Benzatropine—CYP2D6—head—brain cancer	0.00121	0.00873	CbGeAlD
Benzatropine—Constipation—Etoposide—brain cancer	0.00121	0.00656	CcSEcCtD
Benzatropine—Feeling abnormal—Etoposide—brain cancer	0.00116	0.00632	CcSEcCtD
Benzatropine—Vomiting—Carmustine—brain cancer	0.00116	0.00631	CcSEcCtD
Benzatropine—HRH1—brain—brain cancer	0.00115	0.00832	CbGeAlD
Benzatropine—Rash—Carmustine—brain cancer	0.00115	0.00626	CcSEcCtD
Benzatropine—Dermatitis—Carmustine—brain cancer	0.00115	0.00625	CcSEcCtD
Benzatropine—Vomiting—Temozolomide—brain cancer	0.00112	0.0061	CcSEcCtD
Benzatropine—Body temperature increased—Etoposide—brain cancer	0.00112	0.00606	CcSEcCtD
Benzatropine—Rash—Temozolomide—brain cancer	0.00111	0.00604	CcSEcCtD
Benzatropine—Dermatitis—Temozolomide—brain cancer	0.00111	0.00604	CcSEcCtD
Benzatropine—CYP2D6—central nervous system—brain cancer	0.00111	0.00797	CbGeAlD
Benzatropine—Nausea—Carmustine—brain cancer	0.00108	0.00589	CcSEcCtD
Benzatropine—CYP2D6—cerebellum—brain cancer	0.00108	0.00779	CbGeAlD
Benzatropine—CYP2C19—Arachidonic acid metabolism—CYP2C9—brain cancer	0.00105	0.0147	CbGpPWpGaD
Benzatropine—Nausea—Temozolomide—brain cancer	0.00105	0.00569	CcSEcCtD
Benzatropine—Hypersensitivity—Etoposide—brain cancer	0.00104	0.00565	CcSEcCtD
Benzatropine—SLC6A3—Parkinsons Disease Pathway—CCNE1—brain cancer	0.000945	0.0132	CbGpPWpGaD
Benzatropine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000908	0.0127	CbGpPWpGaD
Benzatropine—Vomiting—Etoposide—brain cancer	0.000898	0.00488	CcSEcCtD
Benzatropine—CYP2C19—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000896	0.0126	CbGpPWpGaD
Benzatropine—Rash—Etoposide—brain cancer	0.00089	0.00484	CcSEcCtD
Benzatropine—Dermatitis—Etoposide—brain cancer	0.00089	0.00483	CcSEcCtD
Benzatropine—CYP2D6—brain—brain cancer	0.000878	0.00633	CbGeAlD
Benzatropine—Nausea—Etoposide—brain cancer	0.000839	0.00456	CcSEcCtD
Benzatropine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000835	0.0117	CbGpPWpGaD
Benzatropine—CYP2D6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000824	0.0115	CbGpPWpGaD
Benzatropine—CHRM1—Regulation of Actin Cytoskeleton—PPP1R12A—brain cancer	0.000817	0.0114	CbGpPWpGaD
Benzatropine—CHRM2—Regulation of Actin Cytoskeleton—PPP1R12A—brain cancer	0.000806	0.0113	CbGpPWpGaD
Benzatropine—CYP2C19—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000736	0.0103	CbGpPWpGaD
Benzatropine—CHRM2—SIDS Susceptibility Pathways—HES5—brain cancer	0.0007	0.0098	CbGpPWpGaD
Benzatropine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000677	0.00949	CbGpPWpGaD
Benzatropine—CHRM1—Circadian rythm related genes—NTRK3—brain cancer	0.000598	0.00837	CbGpPWpGaD
Benzatropine—CHRM2—GPCRs, Other—SMO—brain cancer	0.000543	0.00761	CbGpPWpGaD
Benzatropine—SLC6A3—Dopaminergic Neurogenesis—STAT3—brain cancer	0.000487	0.00683	CbGpPWpGaD
Benzatropine—HRH1—IL-4 Signaling Pathway—IRS2—brain cancer	0.000459	0.00643	CbGpPWpGaD
Benzatropine—CYP2C19—Biological oxidations—CYP2C9—brain cancer	0.000391	0.00548	CbGpPWpGaD
Benzatropine—CYP2C19—Metapathway biotransformation—CYP2C9—brain cancer	0.000386	0.0054	CbGpPWpGaD
Benzatropine—CYP2D6—Biological oxidations—CYP2C9—brain cancer	0.00036	0.00504	CbGpPWpGaD
Benzatropine—CYP2D6—Metapathway biotransformation—CYP2C9—brain cancer	0.000355	0.00497	CbGpPWpGaD
Benzatropine—SLC6A3—Transmembrane transport of small molecules—S100A10—brain cancer	0.000338	0.00474	CbGpPWpGaD
Benzatropine—HRH1—GPCR ligand binding—PTCH2—brain cancer	0.00032	0.00449	CbGpPWpGaD
Benzatropine—CHRM1—GPCR ligand binding—PTCH2—brain cancer	0.000319	0.00447	CbGpPWpGaD
Benzatropine—HRH1—IL-4 Signaling Pathway—RELA—brain cancer	0.000317	0.00444	CbGpPWpGaD
Benzatropine—HRH1—G alpha (q) signalling events—TRPC6—brain cancer	0.000316	0.00442	CbGpPWpGaD
Benzatropine—CHRM2—GPCR ligand binding—PTCH2—brain cancer	0.000315	0.00442	CbGpPWpGaD
Benzatropine—CHRM1—G alpha (q) signalling events—TRPC6—brain cancer	0.000315	0.00441	CbGpPWpGaD
Benzatropine—CHRM2—SIDS Susceptibility Pathways—ESR2—brain cancer	0.000298	0.00417	CbGpPWpGaD
Benzatropine—CHRM1—Regulation of Actin Cytoskeleton—VAV1—brain cancer	0.000283	0.00396	CbGpPWpGaD
Benzatropine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—brain cancer	0.000282	0.00395	CbGpPWpGaD
Benzatropine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—brain cancer	0.000281	0.00394	CbGpPWpGaD
Benzatropine—HRH1—GPCR downstream signaling—OR4C12—brain cancer	0.000281	0.00394	CbGpPWpGaD
Benzatropine—HRH1—GPCR downstream signaling—OR14C36—brain cancer	0.000281	0.00394	CbGpPWpGaD
Benzatropine—CHRM1—GPCR downstream signaling—OR4C12—brain cancer	0.00028	0.00392	CbGpPWpGaD
Benzatropine—CHRM1—GPCR downstream signaling—OR14C36—brain cancer	0.00028	0.00392	CbGpPWpGaD
Benzatropine—CHRM2—Regulation of Actin Cytoskeleton—VAV1—brain cancer	0.000279	0.00391	CbGpPWpGaD
Benzatropine—CHRM2—GPCR downstream signaling—OR14C36—brain cancer	0.000276	0.00387	CbGpPWpGaD
Benzatropine—CHRM2—GPCR downstream signaling—OR4C12—brain cancer	0.000276	0.00387	CbGpPWpGaD
Benzatropine—HRH1—Signaling by GPCR—OR4C12—brain cancer	0.000255	0.00357	CbGpPWpGaD
Benzatropine—HRH1—Signaling by GPCR—OR14C36—brain cancer	0.000255	0.00357	CbGpPWpGaD
Benzatropine—CHRM1—Signaling by GPCR—OR14C36—brain cancer	0.000254	0.00356	CbGpPWpGaD
Benzatropine—CHRM1—Signaling by GPCR—OR4C12—brain cancer	0.000254	0.00356	CbGpPWpGaD
Benzatropine—CHRM2—Signaling by GPCR—OR14C36—brain cancer	0.000251	0.00352	CbGpPWpGaD
Benzatropine—CHRM2—Signaling by GPCR—OR4C12—brain cancer	0.000251	0.00352	CbGpPWpGaD
Benzatropine—HRH1—IL-4 Signaling Pathway—STAT3—brain cancer	0.00024	0.00336	CbGpPWpGaD
Benzatropine—CHRM1—Regulation of Actin Cytoskeleton—PDGFRA—brain cancer	0.000231	0.00324	CbGpPWpGaD
Benzatropine—CHRM2—SIDS Susceptibility Pathways—HES1—brain cancer	0.000231	0.00324	CbGpPWpGaD
Benzatropine—CHRM2—Regulation of Actin Cytoskeleton—PDGFRA—brain cancer	0.000229	0.0032	CbGpPWpGaD
Benzatropine—CHRM1—Circadian rythm related genes—SIRT1—brain cancer	0.000198	0.00278	CbGpPWpGaD
Benzatropine—CHRM1—Regulation of Actin Cytoskeleton—APC—brain cancer	0.000179	0.00251	CbGpPWpGaD
Benzatropine—CHRM1—Regulation of Actin Cytoskeleton—PIK3CG—brain cancer	0.000179	0.00251	CbGpPWpGaD
Benzatropine—CHRM2—Regulation of Actin Cytoskeleton—APC—brain cancer	0.000177	0.00248	CbGpPWpGaD
Benzatropine—CHRM2—Regulation of Actin Cytoskeleton—PIK3CG—brain cancer	0.000177	0.00248	CbGpPWpGaD
Benzatropine—HRH1—GPCR ligand binding—SHH—brain cancer	0.000165	0.00231	CbGpPWpGaD
Benzatropine—CHRM1—GPCR ligand binding—SHH—brain cancer	0.000165	0.0023	CbGpPWpGaD
Benzatropine—HRH1—Signaling by GPCR—PTCH2—brain cancer	0.000164	0.0023	CbGpPWpGaD
Benzatropine—CHRM1—Signaling by GPCR—PTCH2—brain cancer	0.000164	0.0023	CbGpPWpGaD
Benzatropine—CHRM2—GPCR ligand binding—SHH—brain cancer	0.000162	0.00228	CbGpPWpGaD
Benzatropine—CHRM2—Signaling by GPCR—PTCH2—brain cancer	0.000162	0.00227	CbGpPWpGaD
Benzatropine—HRH1—GPCR ligand binding—SMO—brain cancer	0.000156	0.00219	CbGpPWpGaD
Benzatropine—HRH1—GPCR ligand binding—PTCH1—brain cancer	0.000156	0.00219	CbGpPWpGaD
Benzatropine—SLC6A3—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000156	0.00219	CbGpPWpGaD
Benzatropine—CHRM1—GPCR ligand binding—PTCH1—brain cancer	0.000156	0.00218	CbGpPWpGaD
Benzatropine—CHRM1—GPCR ligand binding—SMO—brain cancer	0.000156	0.00218	CbGpPWpGaD
Benzatropine—CHRM2—GPCR ligand binding—SMO—brain cancer	0.000154	0.00216	CbGpPWpGaD
Benzatropine—CHRM2—GPCR ligand binding—PTCH1—brain cancer	0.000154	0.00216	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—OR4C12—brain cancer	0.000151	0.00211	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—OR14C36—brain cancer	0.000151	0.00211	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—OR4C12—brain cancer	0.00015	0.0021	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—OR14C36—brain cancer	0.00015	0.0021	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.00015	0.0021	CbGpPWpGaD
Benzatropine—CHRM1—Circadian rythm related genes—CDK4—brain cancer	0.00015	0.0021	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—OR14C36—brain cancer	0.000148	0.00208	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—OR4C12—brain cancer	0.000148	0.00208	CbGpPWpGaD
Benzatropine—HRH1—GPCR downstream signaling—ABR—brain cancer	0.000142	0.00199	CbGpPWpGaD
Benzatropine—CHRM1—GPCR downstream signaling—ABR—brain cancer	0.000142	0.00198	CbGpPWpGaD
Benzatropine—CHRM2—GPCR downstream signaling—ABR—brain cancer	0.00014	0.00196	CbGpPWpGaD
Benzatropine—HRH1—Signaling by GPCR—ABR—brain cancer	0.000129	0.00181	CbGpPWpGaD
Benzatropine—CHRM1—Signaling by GPCR—ABR—brain cancer	0.000129	0.0018	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—DTX2—brain cancer	0.000128	0.0018	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—DTX2—brain cancer	0.000128	0.00179	CbGpPWpGaD
Benzatropine—CHRM2—Signaling by GPCR—ABR—brain cancer	0.000127	0.00178	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—DTX2—brain cancer	0.000126	0.00177	CbGpPWpGaD
Benzatropine—CHRM2—SIDS Susceptibility Pathways—CTNNB1—brain cancer	0.000116	0.00163	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.00011	0.00154	CbGpPWpGaD
Benzatropine—CHRM2—SIDS Susceptibility Pathways—VEGFA—brain cancer	0.000102	0.00143	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—PTCH2—brain cancer	9.71e-05	0.00136	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—PTCH2—brain cancer	9.68e-05	0.00136	CbGpPWpGaD
Benzatropine—CHRM1—Regulation of Actin Cytoskeleton—EGFR—brain cancer	9.66e-05	0.00135	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—PTCH2—brain cancer	9.56e-05	0.00134	CbGpPWpGaD
Benzatropine—CHRM2—Regulation of Actin Cytoskeleton—EGFR—brain cancer	9.54e-05	0.00134	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—HES5—brain cancer	9.41e-05	0.00132	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—HES5—brain cancer	9.38e-05	0.00131	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—HES5—brain cancer	9.26e-05	0.0013	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—STRADA—brain cancer	9.13e-05	0.00128	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—STRADA—brain cancer	9.1e-05	0.00128	CbGpPWpGaD
Benzatropine—HRH1—GPCR downstream signaling—TRPC6—brain cancer	8.99e-05	0.00126	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—STRADA—brain cancer	8.99e-05	0.00126	CbGpPWpGaD
Benzatropine—CHRM1—GPCR downstream signaling—TRPC6—brain cancer	8.97e-05	0.00126	CbGpPWpGaD
Benzatropine—CHRM2—GPCR downstream signaling—TRPC6—brain cancer	8.85e-05	0.00124	CbGpPWpGaD
Benzatropine—HRH1—Signaling by GPCR—SHH—brain cancer	8.47e-05	0.00119	CbGpPWpGaD
Benzatropine—CHRM1—Signaling by GPCR—SHH—brain cancer	8.44e-05	0.00118	CbGpPWpGaD
Benzatropine—CHRM2—Signaling by GPCR—SHH—brain cancer	8.33e-05	0.00117	CbGpPWpGaD
Benzatropine—HRH1—Signaling by GPCR—TRPC6—brain cancer	8.17e-05	0.00114	CbGpPWpGaD
Benzatropine—CHRM1—Signaling by GPCR—TRPC6—brain cancer	8.14e-05	0.00114	CbGpPWpGaD
Benzatropine—CHRM2—Signaling by GPCR—TRPC6—brain cancer	8.04e-05	0.00113	CbGpPWpGaD
Benzatropine—HRH1—Signaling by GPCR—PTCH1—brain cancer	8.03e-05	0.00112	CbGpPWpGaD
Benzatropine—HRH1—Signaling by GPCR—SMO—brain cancer	8.03e-05	0.00112	CbGpPWpGaD
Benzatropine—CHRM1—Signaling by GPCR—PTCH1—brain cancer	8e-05	0.00112	CbGpPWpGaD
Benzatropine—CHRM1—Signaling by GPCR—SMO—brain cancer	8e-05	0.00112	CbGpPWpGaD
Benzatropine—CHRM2—Signaling by GPCR—PTCH1—brain cancer	7.9e-05	0.00111	CbGpPWpGaD
Benzatropine—CHRM2—Signaling by GPCR—SMO—brain cancer	7.9e-05	0.00111	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—ABR—brain cancer	7.62e-05	0.00107	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—ABR—brain cancer	7.6e-05	0.00106	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—ABR—brain cancer	7.5e-05	0.00105	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—GLI2—brain cancer	7.36e-05	0.00103	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—GLI2—brain cancer	7.34e-05	0.00103	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—GLI2—brain cancer	7.24e-05	0.00101	CbGpPWpGaD
Benzatropine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	7.23e-05	0.00101	CbGpPWpGaD
Benzatropine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	7.2e-05	0.00101	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—GLI1—brain cancer	6.92e-05	0.00097	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—GLI1—brain cancer	6.9e-05	0.000966	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—GLI1—brain cancer	6.81e-05	0.000954	CbGpPWpGaD
Benzatropine—HRH1—GPCR downstream signaling—VAV1—brain cancer	6.74e-05	0.000944	CbGpPWpGaD
Benzatropine—CHRM1—GPCR downstream signaling—VAV1—brain cancer	6.72e-05	0.000941	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—CYP2C9—brain cancer	6.69e-05	0.000937	CbGpPWpGaD
Benzatropine—CHRM2—GPCR downstream signaling—VAV1—brain cancer	6.63e-05	0.000929	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—SUFU—brain cancer	6.56e-05	0.000919	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—SUFU—brain cancer	6.54e-05	0.000916	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—SUFU—brain cancer	6.46e-05	0.000904	CbGpPWpGaD
Benzatropine—CHRM1—Circadian rythm related genes—TP53—brain cancer	6.38e-05	0.000894	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—GFAP—brain cancer	6.33e-05	0.000887	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—GFAP—brain cancer	6.31e-05	0.000884	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—GFAP—brain cancer	6.23e-05	0.000873	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—CYP2C9—brain cancer	6.15e-05	0.000862	CbGpPWpGaD
Benzatropine—HRH1—Signaling by GPCR—VAV1—brain cancer	6.12e-05	0.000857	CbGpPWpGaD
Benzatropine—CHRM1—Signaling by GPCR—VAV1—brain cancer	6.1e-05	0.000855	CbGpPWpGaD
Benzatropine—CHRM2—Signaling by GPCR—VAV1—brain cancer	6.02e-05	0.000844	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—HEY1—brain cancer	6e-05	0.000841	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—HEY1—brain cancer	5.98e-05	0.000838	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—HEY1—brain cancer	5.9e-05	0.000827	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—DLL1—brain cancer	5.89e-05	0.000824	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—DLL1—brain cancer	5.87e-05	0.000822	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—DLL1—brain cancer	5.79e-05	0.000811	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—BSG—brain cancer	5.69e-05	0.000797	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—BSG—brain cancer	5.23e-05	0.000733	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—SHH—brain cancer	5e-05	0.000701	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—SHH—brain cancer	4.99e-05	0.000699	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—SHH—brain cancer	4.92e-05	0.00069	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—IDH1—brain cancer	4.89e-05	0.000685	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—TRPC6—brain cancer	4.83e-05	0.000676	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—TRPC6—brain cancer	4.81e-05	0.000674	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—TRPC6—brain cancer	4.75e-05	0.000665	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—SMO—brain cancer	4.74e-05	0.000665	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—PTCH1—brain cancer	4.74e-05	0.000665	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—PTCH1—brain cancer	4.73e-05	0.000662	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—SMO—brain cancer	4.73e-05	0.000662	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—SMO—brain cancer	4.67e-05	0.000654	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—PTCH1—brain cancer	4.67e-05	0.000654	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—IDH1—brain cancer	4.5e-05	0.00063	CbGpPWpGaD
Benzatropine—HRH1—GPCR downstream signaling—PIK3CG—brain cancer	4.28e-05	0.000599	CbGpPWpGaD
Benzatropine—CHRM1—GPCR downstream signaling—PIK3CG—brain cancer	4.27e-05	0.000598	CbGpPWpGaD
Benzatropine—CHRM2—GPCR downstream signaling—PIK3CG—brain cancer	4.21e-05	0.00059	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	3.98e-05	0.000558	CbGpPWpGaD
Benzatropine—HRH1—Signaling by GPCR—PIK3CG—brain cancer	3.89e-05	0.000544	CbGpPWpGaD
Benzatropine—CHRM1—Signaling by GPCR—PIK3CG—brain cancer	3.87e-05	0.000543	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—ENO2—brain cancer	3.87e-05	0.000542	CbGpPWpGaD
Benzatropine—CHRM2—Signaling by GPCR—PIK3CG—brain cancer	3.82e-05	0.000536	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—NOTCH2—brain cancer	3.79e-05	0.000531	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—NOTCH2—brain cancer	3.78e-05	0.00053	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—NOTCH2—brain cancer	3.73e-05	0.000523	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—VAV1—brain cancer	3.62e-05	0.000506	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—VAV1—brain cancer	3.6e-05	0.000505	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—VAV1—brain cancer	3.56e-05	0.000498	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—ENO2—brain cancer	3.56e-05	0.000498	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—HES1—brain cancer	3.11e-05	0.000436	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—HES1—brain cancer	3.1e-05	0.000434	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—HES1—brain cancer	3.06e-05	0.000429	CbGpPWpGaD
Benzatropine—HRH1—GPCR downstream signaling—IL2—brain cancer	3.01e-05	0.000422	CbGpPWpGaD
Benzatropine—CHRM1—GPCR downstream signaling—IL2—brain cancer	3e-05	0.00042	CbGpPWpGaD
Benzatropine—CHRM2—GPCR downstream signaling—IL2—brain cancer	2.96e-05	0.000415	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—PDGFRA—brain cancer	2.96e-05	0.000415	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—PDGFRA—brain cancer	2.95e-05	0.000413	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—PDGFRA—brain cancer	2.91e-05	0.000408	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—SPP1—brain cancer	2.87e-05	0.000403	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—SPP1—brain cancer	2.86e-05	0.000401	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—SPP1—brain cancer	2.83e-05	0.000396	CbGpPWpGaD
Benzatropine—HRH1—Signaling by GPCR—IL2—brain cancer	2.73e-05	0.000383	CbGpPWpGaD
Benzatropine—CHRM1—Signaling by GPCR—IL2—brain cancer	2.73e-05	0.000382	CbGpPWpGaD
Benzatropine—CHRM2—Signaling by GPCR—IL2—brain cancer	2.69e-05	0.000377	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—IRS2—brain cancer	2.6e-05	0.000364	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—IRS2—brain cancer	2.59e-05	0.000363	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—IRS2—brain cancer	2.56e-05	0.000358	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—PIK3CG—brain cancer	2.3e-05	0.000322	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—APC—brain cancer	2.3e-05	0.000322	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—PIK3CG—brain cancer	2.29e-05	0.000321	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—APC—brain cancer	2.29e-05	0.000321	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—APC—brain cancer	2.26e-05	0.000316	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—PIK3CG—brain cancer	2.26e-05	0.000316	CbGpPWpGaD
Benzatropine—HRH1—Signaling by GPCR—EGFR—brain cancer	2.09e-05	0.000293	CbGpPWpGaD
Benzatropine—CHRM1—Signaling by GPCR—EGFR—brain cancer	2.08e-05	0.000292	CbGpPWpGaD
Benzatropine—CHRM2—Signaling by GPCR—EGFR—brain cancer	2.06e-05	0.000288	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—RELA—brain cancer	1.79e-05	0.000251	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—RELA—brain cancer	1.79e-05	0.00025	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—ERBB2—brain cancer	1.78e-05	0.00025	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—ERBB2—brain cancer	1.78e-05	0.000249	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—PIK3CG—brain cancer	1.77e-05	0.000248	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—RELA—brain cancer	1.76e-05	0.000247	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—ERBB2—brain cancer	1.75e-05	0.000246	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—PIK3CG—brain cancer	1.63e-05	0.000228	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—IL2—brain cancer	1.62e-05	0.000226	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—IL2—brain cancer	1.61e-05	0.000226	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—IL2—brain cancer	1.59e-05	0.000223	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—CCND1—brain cancer	1.57e-05	0.000221	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—CCND1—brain cancer	1.57e-05	0.00022	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—CTNNB1—brain cancer	1.56e-05	0.000218	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—CTNNB1—brain cancer	1.55e-05	0.000218	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—CCND1—brain cancer	1.55e-05	0.000217	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—CTNNB1—brain cancer	1.53e-05	0.000215	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—VEGFA—brain cancer	1.37e-05	0.000192	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—VEGFA—brain cancer	1.37e-05	0.000192	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—STAT3—brain cancer	1.36e-05	0.00019	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—STAT3—brain cancer	1.35e-05	0.00019	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—VEGFA—brain cancer	1.35e-05	0.000189	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—STAT3—brain cancer	1.34e-05	0.000187	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—MYC—brain cancer	1.26e-05	0.000177	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—MYC—brain cancer	1.26e-05	0.000176	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—MYC—brain cancer	1.24e-05	0.000174	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—EGFR—brain cancer	1.24e-05	0.000173	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—EGFR—brain cancer	1.23e-05	0.000173	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—EGFR—brain cancer	1.22e-05	0.00017	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—TP53—brain cancer	1.04e-05	0.000145	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—TP53—brain cancer	1.03e-05	0.000145	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—TP53—brain cancer	1.02e-05	0.000143	CbGpPWpGaD
